Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05419531 · ClinicalTrials.gov registry record
The Purpose of This Study is to Determine the Frequency of Colorectal Cancer in Male and Female Endurance Athletes Between the Ages of 35 and 50
A clinical trial, sponsored by Inova Health Care Services.
- Completed
- Registry status
- 94
- Enrollment target
NCT05419531: Completed study, sponsored by Inova Health Care Services.
NCT05419531 is a clinical trial that has completed, run by Inova Health Care Services. The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05419531 has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the frequency of colorectal cancer in male and female endurance athletes between the ages of 35 and 50.
Primary Outcome
1. Estimate the rate of young endurance runners that have adenomatous polyps. 2. Estimate the rate of young endurance runners that have advanced adenoma and colorectal cancer on screening colonoscopies.
Interventions
- OTHER prospective observational study - screening and follow up colonoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2022-10-18 |
| Est. Completion | 2025-10-22 |
What the finished NCT05419531 record still lists
NCT05419531 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which prospective observational study - screening and follow up colonoscopy is the first listed.
NCT05419531 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05419531 about?
NCT05419531 is a clinical study titled "The Purpose of This Study is to Determine the Frequency of Colorectal Cancer in Male and Female Endurance Athletes Between the Ages of 35 and 50". The purpose of this study is to determine the frequency of colorectal cancer in male and female endurance athletes between the ages of 35 and 50.
What is the current status of trial NCT05419531?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2022-10-18. Estimated completion is 2025-10-22.
What interventions are being tested in trial NCT05419531?
The interventions under investigation include: prospective observational study - screening and follow up colonoscopy (OTHER).
Who is sponsoring clinical trial NCT05419531?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI